NASDAQ: AVGR - Avinger, Inc.

半年間の収益性: -71.99%
セクタ: Healthcare

プロモーションスケジュール Avinger, Inc.


会社について

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

さらに詳しく
The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.

EBITDA -0.0185
EV/EBITDA -0.6146
IPO date 2015-01-30
ISIN US0537348858
Industry Health Care Equipment & Supplies
P/BV 1.23
P/S 0.9276
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0091
Сайт https://avinger.com
Цена ао 2.95
Число акций ао 0.000786 млрд
1日あたりの価格変動: -18.53% (1.29)
週ごとの価格変動: +6.72% (0.9847)
月ごとの料金変更: +11.03% (0.9465)
3ヶ月間の価格変動: -37.07% (1.67)
半年間の価格変動: -71.99% (3.7523)
年間の価格変動: -76.12% (4.4)
3年間の価格推移: +25.86% (0.835)
5年間の価格推移: -7.82% (1.14)
年初からの価格変動: -75.9% (4.36)

過小評価

名前 意味 学年
P/S 0.2825 10
P/BV -0.3485 0
P/E 0 0
EV/EBITDA -0.8056 0
合計: 5

効率

名前 意味 学年
ROA, % -133.04 0
ROE, % 295.39 10
合計: 3.33

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -1.01 10
合計: 9.6

成長の衝動

名前 意味 学年
収益性 Revenue, % -15.91 0
収益性 Ebitda, % -21.41 0
収益性 EPS, % -57.29 0
合計: 0



スーパーバイザー 役職 支払い 生年
Mr. Jeffrey M. Soinski CEO & Director 616.79k 1962 (62 年)
Mr. Nabeel P. Subainati Vice President of Finance 347.58k 1984 (40 年)
Mr. Himanshu N. Patel Chief Technology Officer 430.08k 1960 (64 年)
Mr. Keith Schaefer Chief Operating Officer N/A
Mr. Corey Gibbs Vice President of Sales N/A
Dr. Jaafer Golzar FACC, M.D. Chief Medical Officer N/A
Mr. Philip R. Preuss Chief Marketing Officer & VP of Business Operations N/A 1978 (46 年)

住所: United States, Redwood City. CA, 400 Chesapeake Drive - Googleマップで開く, Yandexマップを開く
Webサイト: https://avinger.com